Maven Securities’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7,186
Closed -$613K 515
2025
Q2
$653K Buy
+7,186
New +$656K 0.02% 539
2024
Q4
Sell
-3,093
Closed -$295K 843
2024
Q3
$321K Sell
3,093
-4,757
-61% -$485K 0.01% 754
2024
Q2
$762K Buy
7,850
+2,547
+48% +$235K 0.02% 584
2024
Q1
$478K Sell
5,303
-1,142
-18% -$96.8K 0.03% 222
2023
Q4
$514K Buy
+6,445
New +$485K 0.01% 655
2023
Q1
Sell
-4,661
Closed -$347K 937
2022
Q4
$367K Buy
4,661
+1,373
+42% +$103K 0.01% 642
2022
Q3
$231K Buy
+3,288
New +$258K ﹤0.01% 1011
2022
Q1
Sell
-4,463
Closed -$354K 988
2021
Q4
$381K Sell
4,463
-2,687
-38% -$210K 0.01% 622
2021
Q3
$540K Buy
7,150
+3,630
+103% +$288K 0.02% 636
2021
Q2
$286K Buy
3,520
+1,535
+77% +$126K 0.01% 838
2021
Q1
$156K Buy
+1,985
New +$156K 0.01% 952
2018
Q4
Sell
-10,888
Closed -$728K 98
2018
Q3
$728K Hold
10,888
0.27% 83
2018
Q2
$709K Hold
10,888
0.39% 43
2018
Q1
$780K Buy
+10,888
New +$784K 0.41% 41

Other funds holding CL

Maven Securities's CL Position: Q3 2025 in Review

Maven Securities sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 7,186 shares — an estimated $613K sold.

Maven Securities first reported a position in CL in Q1 2018 and held it in 14 quarters. The position peaked at $780K in Q1 2018. 1,845 funds tracked by Wall St. Rank hold CL as of Q3 2025.

  • Maven Securities reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
  • Maven Securities sold 7,186 Colgate-Palmolive shares in Q3 2025, an estimated $613K.
  • Maven Securities first reported a position in Colgate-Palmolive in Q1 2018 and held it in 14 quarters.
  • Maven Securities's Colgate-Palmolive position peaked at $780K in Q1 2018.
  • 1,845 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Maven Securities's 13F filing for Q3 2025, filed 20 Nov 2025.